Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Regorafenib in metastatic colorectal cancer: optimal dosing and patient selection recommendations.. Retrieved May 24, 2026, from https://4ort.xyz/entity/regorafenib-in-metastatic-colorectal-cancer-optimal-dosing-and-patient-selection-recommendations
MLA“Regorafenib in metastatic colorectal cancer: optimal dosing and patient selection recommendations..” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/regorafenib-in-metastatic-colorectal-cancer-optimal-dosing-and-patient-selection-recommendations.
BibTeX@misc{4ortxyz_regorafenib-in-metastatic-colorectal-cancer-optimal-dosing-and-patient-selection-recommendations_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Regorafenib in metastatic colorectal cancer: optimal dosing and patient selection recommendations.}}, year = {2026}, url = {https://4ort.xyz/entity/regorafenib-in-metastatic-colorectal-cancer-optimal-dosing-and-patient-selection-recommendations}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Regorafenib in metastatic colorectal cancer: optimal dosing and patient selection recommendations. — https://4ort.xyz/entity/regorafenib-in-metastatic-colorectal-cancer-optimal-dosing-and-patient-selection-recommendations (retrieved 2026-05-24)
